European Medicines Agency

European Medicines Agency

Priority Medicines (PRIME): Medicines targeting unmet medical needs
Priority Medicines (PRIME): Medicines targeting unmet medical needs
Learn how the European Medicines Agency's PRIME (PRIority MEdicines) scheme helps accelerate the development of promising medicines for patients with unmet medical needs. In this video, Kevin Cunn...
Priority Medicines (PRIME): Medicines targeting unmet medical needs
Priority Medicines (PRIME): Medicines targeting unmet medical needs
Learn how the European Medicines Agency's PRIME (PRIority MEdicines) scheme helps accelerate the development of promising medicines for patients with unmet medical needs. In this video, Kevin Cunn...
Public System Demo Q2 2026
Public System Demo Q2 2026
00:00:48 Welcome & Introduction 00:05:00 Union Product Database (UPD) 00:17:05 Regulatory Procedure Management (RPM) for Product Lifecycle Management on IRIS 00:45:53 Electronic product inform
Product Management Service (PMS) Info day - June 2026
Product Management Service (PMS) Info day - June 2026
00:00 - 9:20 Emer Cooke opening remarks 9:21 - 16:09 Karl Broich opening remarks 16:10 - 21:32 Runa Hauksdottir Hvannberg opening remarks 21:33 - 26:04 Housekeeping and agenda 26:05 - 49:42 Session...
Evidence for two: medicines in pregnancy and breastfeeding.
Evidence for two: medicines in pregnancy and breastfeeding.
Corinne de Vries, EMA lead on medicines in pregnancy and breastfeeding, explains how better safety data can be generated at every stage of a medicine’s lifecycle.
Inside EMA: Evidence for two: medicines in pregnancy and breastfeeding.
Inside EMA: Evidence for two: medicines in pregnancy and breastfeeding.
Up to 90% of women who are pregnant or breastfeeding use medicines, yet for many of these treatments, reliable safety data remains limited. Why does this gap exist—and how can it be addressed? In ...
BfArM and EMA: Data, AI and medicines regulation in Europe
BfArM and EMA: Data, AI and medicines regulation in Europe
What does the future of medicines regulation look like in the age of AI and big data? In this conversation, Prof. Dr. Karl Broich, President of BfArM, and Dr. Peter Arlett, Head of the Data Analyti...
Data trust and the future of medicines
Data trust and the future of medicines
From clinical trials to real world evidence. How is data shaping the future of medicines? Discover how EMA uses data to guide safer, better decisions. In this episode of Inside EMA, we explore ho...
S01E07 Data trust and the future of medicines
S01E07 Data trust and the future of medicines
From clinical trials to real world evidence. How is data shaping the future of medicines? Discover how EMA uses data to guide safer, better decisions. In this episode of Inside EMA, we explore ho...
Explaining Clinical Trials
Explaining Clinical Trials
In this video, we describe the role of clinical trials in the development and approval of medicines. Learn how researchers test thousands of substances, how clinical trials are carefully designed...
Explaining Clinical Trials (Short version)
Explaining Clinical Trials (Short version)
In this video, we describe the role of clinical trials in the development and approval of medicines. Learn how researchers test thousands of substances, how clinical trials are carefully designed...
Explaining Clinical Trials
Explaining Clinical Trials
In this video, we describe the role of clinical trials in the development and approval of medicines. Learn how researchers test thousands of substances, how clinical trials are carefully designed...
Approval of a medicine in the EU: the people involved
Approval of a medicine in the EU: the people involved
Who are the people behind the approval of medicines in the EU? Meet the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), the scientific committee responsible for e...